Analyst Ratings for Avita Medical Ltd. (RCEL)
RCEL Rating Summary
RCEL Price Target Summary
- Highest: $14.00 (D. Boral Capital)
- Lowest: $6.00 (Lake Street )
- Average: $10.25
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$10.25 (+155.6%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 79%
Avg. $ Target:
$10.25 (+155.6%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 79%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/15/2026 | Lake Street | Frank Takkinen | Upgrade | Buy (Hold) |
6.00 (N/A) |
4.36 (4.01) |
-8.03% | Details |
| 3/5/2026 | Northland | Carl Byrnes Jr. | New Coverage | Outperform (N/A) |
10.00 (N/A) |
4.96 (4.01) |
-19.15% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
